Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive molecular profiling broadens treatment options for breast cancer patients.

Cancer medicine - 1 Jan 2021

Kawaji Hitomi, Kubo Makoto, Yamashita Nami, Yamamoto Hidetaka, Kai Masaya, Kajihara Atsuko, Yamada Mai, Kurata Kanako, Kaneshiro Kazuhisa, Harada Yurina, Hayashi Saori, Shimazaki Akiko, Mori Hitomi, Akiyoshi Sayuri, Oki Eiji, Oda Yoshinao, Baba Eishi, Mori Masaki, Nakamura Masafumi

Abstract excerpt

Precision oncology with next generation sequencing (NGS) using tumor tissue with or without blood has begun in Japan. Tumor molecular profiling tests are available, including the OncoGuide™ NCC Oncopanel System and FoundationOne® CDx (F1CDx). Our purpose was to identify potentially actionable genetic alterations in breast cancer with this comprehensive tumor profiling test. We enrolled 115 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Support Techniques

Share to Follow-Up Studies

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33274848
DOI: 10.1002/cam4.3619
PMCID: PMC7877356

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive molecular profiling broadens treatment options for breast cancer patients.PMID 33274848Read ↗

Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine.Semantic proximity Read ↗

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.Semantic proximity Read ↗

Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.Semantic proximity Read ↗

Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity Read ↗

Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors.Semantic proximity Read ↗

Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic options.Semantic proximity Read ↗

Comprehensive Genomic Profiling of Taiwanese Breast Cancer Using a Novel Targeted Sequencing PanelSemantic proximity Read ↗

Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese PopulationSemantic proximity Read ↗

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.Semantic proximity Read ↗

Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast CancerSemantic proximity Read ↗

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.Semantic proximity Read ↗

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatmentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.